These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Patenting applied to genetic sequence information. Duval M; Hsieh TF Biotechnol Genet Eng Rev; 2006; 23():317-30. PubMed ID: 22530515 [No Abstract] [Full Text] [Related]
4. DNA patenting: the end of an era? Hopkins MM; Mahdi S; Patel P; Thomas SM Nat Biotechnol; 2007 Feb; 25(2):185-7. PubMed ID: 17287750 [TBL] [Abstract][Full Text] [Related]
5. Shares in the human genome--the future of patenting DNA. Thomas SM; Hopkins MM; Brady M Nat Biotechnol; 2002 Dec; 20(12):1185-8. PubMed ID: 12454661 [No Abstract] [Full Text] [Related]
7. Impact of gene patenting on R&D and commerce. Stott M; Valentine J Nat Biotechnol; 2003 Jul; 21(7):729-31; author reply 731. PubMed ID: 12833081 [No Abstract] [Full Text] [Related]
8. From human genes to stem cells: new challenges for patent law? Caulfield TA Trends Biotechnol; 2003 Mar; 21(3):101-3. PubMed ID: 12628363 [TBL] [Abstract][Full Text] [Related]
9. Transparency tools in gene patenting for informing policy and practice. Jefferson OA; Köllhofer D; Ehrich TH; Jefferson RA Nat Biotechnol; 2013 Dec; 31(12):1086-93. PubMed ID: 24316644 [TBL] [Abstract][Full Text] [Related]
10. Biotechnology patents under fire. Royzman I Nat Biotechnol; 2015 Sep; 33(9):925-6. PubMed ID: 26348959 [No Abstract] [Full Text] [Related]
11. A nail in the coffin for DNA sequence patents? Yamanaka M Nat Biotechnol; 2008 Oct; 26(10):1085-6. PubMed ID: 18846072 [No Abstract] [Full Text] [Related]
12. Patentability of synthetic biology inventions in Europe. Rutz B Biotechnol J; 2010 Jan; 5(1):11-3. PubMed ID: 20069577 [No Abstract] [Full Text] [Related]
13. Ownership at too high a price? Nat Biotechnol; 2003 Sep; 21(9):953. PubMed ID: 12949537 [No Abstract] [Full Text] [Related]
14. Patent protection and access to genetic resources. Shimbo I; Ito Y; Sumikura K Nat Biotechnol; 2008 Jun; 26(6):645-7. PubMed ID: 18536683 [TBL] [Abstract][Full Text] [Related]
15. US court case to define EST patentability. Lawrence S Nat Biotechnol; 2005 May; 23(5):513. PubMed ID: 15877055 [No Abstract] [Full Text] [Related]
16. A Lockean argument against gene patenting. Murray D Bus Prof Ethics J; 2001; 20(3-4):129-43. PubMed ID: 15195649 [No Abstract] [Full Text] [Related]
17. Patenting pluripotence: the next battle for stem cell intellectual property. Vrtovec KT; Scott CT Nat Biotechnol; 2008 Apr; 26(4):393-5. PubMed ID: 18392018 [TBL] [Abstract][Full Text] [Related]
18. The human genome as common heritage: common sense or legal nonsense? Ossorio PN J Law Med Ethics; 2007; 35(3):425-39. PubMed ID: 17714252 [TBL] [Abstract][Full Text] [Related]
19. Biotechs sue Columbia over fourth Axel patent. Howard K Nat Biotechnol; 2003 Sep; 21(9):955-6. PubMed ID: 12949538 [No Abstract] [Full Text] [Related]
20. Who owns the human genome? What can ownership mean with respect to genes? Markl H IIC Int Rev Ind Prop Copyr Law; 2002; 33(1):1-5. PubMed ID: 15156889 [No Abstract] [Full Text] [Related] [Next] [New Search]